Henry Schein Inc
$ 80.22
1.74%
11 Jun - close price
- Market Cap 9,116,758,000 USD
- Current Price $ 80.22
- High / Low $ 80.51 / 78.79
- Stock P/E 24.18
- Book Value 28.54
- EPS 3.31
- Next Earning Report 2026-08-04
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.04 %
- ROE 0.09 %
- 52 Week High 89.29
- 52 Week Low 61.95
About
Henry Schein, Inc. is an American distributor of health care products and services with a presence in 32 countries.
Analyst Target Price
$87.21
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-05 | 2026-02-24 | 2025-11-04 | 2025-08-05 | 2025-05-05 | 2025-02-25 | 2024-11-05 | 2024-08-06 | 2024-05-07 | 2024-02-27 | 2023-11-13 | 2023-08-07 |
| Reported EPS | 1.32 | 1.34 | 1.38 | 0.7 | 0.88 | 1.19 | 1.22 | 1.23 | 1.1 | 0.66 | 1.32 | 1.31 |
| Estimated EPS | 1.22 | 1.3 | 1.28 | 0.92 | 0.9 | 1.2089 | 1.17 | 1.22 | 1.01 | 0.69 | 1.32 | 1.28 |
| Surprise | 0.1 | 0.04 | 0.1 | -0.22 | -0.02 | -0.0189 | 0.05 | 0.01 | 0.09 | -0.03 | 0 | 0.03 |
| Surprise Percentage | 8.1967% | 3.0769% | 7.8125% | -23.913% | -2.2222% | -1.5634% | 4.2735% | 0.8197% | 8.9109% | -4.3478% | 0% | 2.3438% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-04 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 1.23 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: HSIC
2026-06-11 17:18:00
Henry Schein Inc. (HSIC) stock increased by 1.74% on Thursday, reaching $80.22. Despite this rise, the company's performance underperformed the broader market, as both the S&P 500 Index and the Dow Jones Industrial Average saw larger gains. The stock remains 10.16% below its 52-week high of $89.29, achieved in February.
2026-06-11 12:07:52
JPMorgan Chase & Co. decreased its stake in Henry Schein, Inc. by 17.8% in Q4, selling over a million shares. Despite this, Henry Schein reported strong Q1 results, exceeding earnings and revenue estimates. Insider activity at Henry Schein was mixed, with the CEO selling shares and a director purchasing a substantial amount.
2026-06-11 12:04:47
Several top Wall Street analysts have upgraded their ratings for five major companies. Henry Schein Inc. saw an upgrade from Neutral to Buy with a $100 price target. Other companies receiving upgrades include Black Hills Corp., Intel Corp., Tronox Holdings PLC, and CME Group Inc., with increased price targets reflecting a bullish outlook from various financial institutions.
2026-06-11 11:37:50
Heartland Advisors Inc. has acquired a new stake of 120,000 shares in Henry Schein, Inc. (NASDAQ:HSIC) during the fourth quarter, valued at approximately $9.07 million. Institutional ownership of Henry Schein remains very high at 96.62%, and the company recently exceeded quarterly earnings expectations with $1.32 EPS and revenue of $3.37 billion. Analysts currently hold a consensus "Hold" rating for HSIC with a target price of $86.83.
2026-06-11 10:37:51
BTIG has upgraded Henry Schein (HSIC) to a "Buy" rating from "Neutral," setting a new price target of $100. This upgrade indicates a more positive outlook on the company's stock performance by the analyst firm. The article also provides a company profile for Henry Schein, detailing its business segments in healthcare product distribution and services.
2026-06-11 10:30:44
BTIG upgraded Henry Schein (NASDAQ:HSIC) to Buy from Neutral, setting a price target of $100 due to strong first-quarter 2026 U.S. dental growth, healthy market sentiment, and margin expansion. Despite the stock showing a 10.84% return over the past year, InvestingPro suggests it is slightly overvalued relative to its Fair Value. Henry Schein also recently surpassed Q1 2026 earnings and revenue expectations, although concerns about future guidance led to a premarket stock decline.
